TrialBlood advances2019

Phase 2 study of clarithromycin, pomalidomide, and dexamethasone in relapsed or refractory multiple myeloma.

Tomer M Mark et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.